A review of oxycodone’s clinical pharmacokinetics and pharmacodynamics

Author: Poyhia, R; Vainio, A; Kalso, E

Description: Oxycodone (14-hydroxy-7,8-dihydrocodeinone) is a strong opioid agonist that is available alone or in combination with mild analgesics. It is suitable for oral administration due to high bioavailability (60%), and may also be given intramuscularly, intravenously, subcutaneously, and rectally; it is not recommended for spinal administration. In analgesic potency, oxycodone is comparable to morphine. With the exception of hallucinations, which may occur more rarely after oxycodone than after morphine, the side effects of these drugs are closely related. The abuse potential of oxycodone is equivalent to that of morphine. The usual indications for oxycodone are severe acute postoperative or posttraumatic pain and cancer pain. When oxycodone is administered, the same precautions should be taken as with morphine or other agonist opioids.

Subject headings: Biological Availability; Humans; Oxycodone/administration & dosage/pharmacokinetics/pharmacology; Therapeutic Equivalency

Publication year: 1993

Journal or book title: Journal of pain and symptom management

Volume: 8

Issue: 2

Pages: 63-67

Find the full text: https://www.sciencedirect.com/science/article/pii/088539249390101Z

Find more like this one (cited by): https://scholar.google.com/scholar?cites=327132601404420575&as_sdt=1000005&sciodt=0,16&hl=en

Serial number: 4214

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.